Popular on EntSun
- Female Motorsports Sponsorship & Expansion; Acquisition Agreement of UAE-Based Sports Incubator by Online Lottery & Sports Game Provider: Lottery.com - 238
- WOA Entertainment Group Unveils Independent No.1's: Breakthrough Artists II —A Celebration of Indie Excellence - 220
- Experience Trembling Firsthand with the New AgeMan® Tremor Simulator - 218
- Edtech Startup Young Commanders Launches 'Visionaries Without Sight' Collection Celebrating Blind and Visually Impaired Historical Figures - 211
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement - 194
- Let's Talk Series: At the Crossroads: Immigration Today - 159
- BillBoards Inc. Hits the Road with God Bless America Tour and Reality Series Now Streaming on Tubi TV - 145
- Token-Operated Sake Service Opens at Tobu Nikko Station - 131
- Honoring Black History, Culture, and Community in Fall River - 129
- databahn Launches GenAI Sales Intelligence Platform to Revolutionize Fortune 500 and Global 2000 Account Research - 117
Similar on EntSun
- LIB and Nidec Rejoin Forces for Giant TH-0098 Temperature Humidity Test Chamber
- NASA Collaborative Agreement for Supply of Thin-Film Solar Tech for Orbital Application to Advance Development of Thin-Film PV Power Beaming: $ASTI
- Service Ninjas Debuts First-of-Its-Kind "Membership" Platform for Home Service Pros
- BIYA Forecasts 2025 Surge with ¥300M ($41.8 M USD) in Revenue and ¥25M Profit from Cloud Based HR Solutions: Baiya Intl. Group (N A S D A Q: BIYA)
- Paul E. Saperstein Co. Announces Geographic Expansion of Auction Services
- Melissa B. Releases Digitally Independent: Empowering Music Artists with AI and Brand Strategy
- NR7 Miner launches zero-cost USDT cloud mining service: daily stable income + referral rewards for double profit
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
Late Breaking Clinical Research Coming to Heart Failure Society of America Annual Scientific Meeting September 27-30
EntSun News/11035774
WASHINGTON, Sept. 5, 2024 /PRNewswire/ -- The Heart Failure Society of America (HFSA) is pleased to announce the Late Breaking Clinical Research that will be presented at its Annual Scientific Meeting (ASM), September 27-30, at the Georgia World Congress Center and the new Signia by Hilton Atlanta in Atlanta, GA.
Late breaking clinical research to be featured during two plenary sessions includes results and updates from these major randomized trials:
Sunday, September 29 Plenary Session | 9:00 AM – 10:30 AM
Monday, September 30 Plenary Session | 9:00 AM – 10:30 AM
Late Breaking Clinical Research showcases novel results of major randomized trials and rapidly evolving research. Leaders of the field will serve as discussants, presenting brief comments about each trial to place them in context.
Due to the quantity of remarkable trials submitted, HFSA will also feature late breaking research through Rapid Fire Oral Sessions. These Rapid Fire sessions are fast-paced and brief oral presentations spotlighting key data from late breaking clinical research. Sessions take place on Saturday, Sunday and Monday with moderated Q&A and a new topic each day.
Saturday, September 28 | Rapid Fire 1: Not Just Plug and Play: Devices and Health Technology in Heart Failure | 4:00 PM - 5:00 PM
Sunday, September 29 | Rapid Fire 2: Birds of a Feather: Cardio-kidney-metabolism and HFpEF | 5:15 PM - 6:15 PM
Monday, September 30 | Rapid Fire 3: See One, Do One: Emerging Therapeutic Strategies in Cardiomyopathies and Heart Failure | 10:45 AM - 11:45 AM
The meeting kicks off in just three weeks. A full schedule at a glance is available online, as well as information on the science and research and networking available at the meeting. Learn more about the meeting and register at hfsa.org/asm2024.
More on EntSun News
About the Heart Failure Society of America
The Heart Failure Society of America, Inc. (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care. The mission of HFSA is to provide a platform to improve and expand heart failure care through collaboration, education, innovation, research, and advocacy. HFSA members include physicians, scientists, nurses, nurse practitioners, pharmacists, trainees, other healthcare workers and patients. For more information, visit hfsa.org.
Media Contact: Laura Poko, 301-798-4493, ext. 226, [email protected]
SOURCE Heart Failure Society of America
Late breaking clinical research to be featured during two plenary sessions includes results and updates from these major randomized trials:
Sunday, September 29 Plenary Session | 9:00 AM – 10:30 AM
- STEP-HFpEF
- Efficacy Of Semaglutide In Patients With Obesity And HFpEF According To Frailty Status: A Pooled Analysis From The STEP-HFpEF Program
- Effects Of Semaglutide In Patients With Obesity-related Heart Failure With Preserved Ejection Fraction According To The Exercise Function At Baseline: Insights From The STEP-HFpEF Program
- FINEARTS-HF
- Efficacy And Safety Of Finerenone In Patients With Heart Failure And Mildly Reduced Or Preserved Ejection Fraction And A Recent Worsening Heart Failure Event: The FINEARTS-HF Trial
- Efficacy And Safety Of Finerenone Across The Ejection Fraction Spectrum In Heart Failure With Mildly Reduced And Preserved Ejection Fraction: The FINEARTS-HF Trial
- HELIOS-B
- Exploratory Analyses From HELIOS-B, A Phase 3 Study Of Vutisiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Title to be announced
Monday, September 30 Plenary Session | 9:00 AM – 10:30 AM
- SEQUOIA-HCM
- Global Clinical Impact Of Aficamten In Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
- Global Clinical Impact Of Aficamten In Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
- EMBARK-HFpEF
- Myosin Inhibition In Heart Failure With Preserved Ejection Fraction: Primary Results Of The EMBARK HFpEF Trial
- Myosin Inhibition In Heart Failure With Preserved Ejection Fraction: Primary Results Of The EMBARK HFpEF Trial
- ARIES-HM3
- Impact Of Pharmacological Therapy On Hemocompatibility Following Left Ventricular Assist Device Implantation: An Analysis From The ARIES-HM3 Trial
- Impact Of Pharmacological Therapy On Hemocompatibility Following Left Ventricular Assist Device Implantation: An Analysis From The ARIES-HM3 Trial
- EXPANDed
- Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair With The MitraClip System
More on EntSun News- Exciting New Era of Sports, Entertainment & Gaming Innovation Spotlighted by Rebrand of Expanding AI Driven, Online Fan Engagement Company: SEGG Media
- Service Ninjas Debuts First-of-Its-Kind "Membership" Platform for Home Service Pros
- Bruce In The USA Brings Immersive Bruce Springsteen Celebration to Frederick This October
- BIYA Forecasts 2025 Surge with ¥300M ($41.8 M USD) in Revenue and ¥25M Profit from Cloud Based HR Solutions: Baiya Intl. Group (N A S D A Q: BIYA)
- Paul E. Saperstein Co. Announces Geographic Expansion of Auction Services
- Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair With The MitraClip System
- HuMAIN-HFpEF
- A Novel Controlled Metabolic Accelerator For The Treatment Of Obesity-related Heart Failure With Preserved Ejection Fraction: HuMAIN-HFpEF Trial
Late Breaking Clinical Research showcases novel results of major randomized trials and rapidly evolving research. Leaders of the field will serve as discussants, presenting brief comments about each trial to place them in context.
Due to the quantity of remarkable trials submitted, HFSA will also feature late breaking research through Rapid Fire Oral Sessions. These Rapid Fire sessions are fast-paced and brief oral presentations spotlighting key data from late breaking clinical research. Sessions take place on Saturday, Sunday and Monday with moderated Q&A and a new topic each day.
Saturday, September 28 | Rapid Fire 1: Not Just Plug and Play: Devices and Health Technology in Heart Failure | 4:00 PM - 5:00 PM
- Interstitial Decongestion with Device-Based Thoracic Duct Decompression in Acute Decompensated Heart Failure Patients
- RECOVER-HFPilot Study: Synchronized Diaphragmatic Stimulation For HFrEF Therapy
- PROACTIVE HF: 12-Month Results
- Safety And Technical Endpoints And Accurate Volume Assessment Using An Implanted Inferior Vena Cava Sensor
- Electronic Alerts To Improve Heart Failure Therapy Throughout An Integrated Health System: Prompt-HF Inova
- Effect Of Finerenone On Kansas City Cardiomyopathy Questionnaire (KCCQ) Score In Heart Failure With Mildly Reduced And Preserved Ejection Fraction: The FINEARTS-HF Trial
Sunday, September 29 | Rapid Fire 2: Birds of a Feather: Cardio-kidney-metabolism and HFpEF | 5:15 PM - 6:15 PM
- Efficacy And Safety Of Finerenone According To Age In Heart Failure With Mildly Reduced And Preserved Ejection Fraction: The FINEARTS-HF Trial
- The Effects Of Burst Steroid Therapy On Short Term Decongestion In Acute Heart Failure: The CORTAHF Randomized, Open-Label, Pilot Trial
- Effects Of Exogenous Ketone Therapy On Exercise Capacity In Heart Failure With Preserved Ejection Fraction: KETO-HFpEF
- Metabolic Responses To Exercise Following Weight Loss Surgery: WTLOSS-EX Trial
- Efficacy Of A Home-Based M-Health Cardiac Rehabilitation Program Among Older Adults With Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Controlled Trial
- Understanding The Real-World Management Of Patients With Heart Failure At Risk For Hyperkalemia: Initial Results From The CARE-HK In Heart Failure (HF) Registry
- Unsaturated Fatty Acids To Improve Cardiorespiratory Fitness In Obesity-Related Heart Failure With Preserved Ejection Fraction: The UFA-Preserved2 Randomized Controlled Cross-over Study
Monday, September 30 | Rapid Fire 3: See One, Do One: Emerging Therapeutic Strategies in Cardiomyopathies and Heart Failure | 10:45 AM - 11:45 AM
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study On The Safety And Efficacy Of Istaroxime For Pre-Cardiogenic Shock
- First In Human Gene Therapy For The Cardiomyopathy Of Friedreich Ataxia
- Differences In Self -care Of Heart Failure Index Among Patients With Heart Failure With And Without Symptom Coaching Messages: A Pilot Clinical Trial Study
- Efficacy Of Single Dose Furoscix Vs. Home Dose Furosemide In Patients Recently Hospitalized For Heart Failure Across Diuretic Resistance Strata: A Pilot Randomized Controlled Trial
- AuXillary OUTpatient Management Of VAD BLEEDing: The AXOUT VAD BLEED Pilot Study
- Pulmonary Artery Pressures In Relation To Serial Cardiovascular Blood Biomarkers In Chronic Heart Failure Patients
- American Registry Of Ambulatory Or Acute Decompensated Heart Failure (AMERICCAASS): Current Results
The meeting kicks off in just three weeks. A full schedule at a glance is available online, as well as information on the science and research and networking available at the meeting. Learn more about the meeting and register at hfsa.org/asm2024.
More on EntSun News
- Florida Broker Bent Danholm Featured in the Daily Mail's U.S. Real Estate Coverage
- Robin Launches Legal Intelligence Platform to solve intelligence gap in Fortune 500 legal teams
- Melissa B. Releases Digitally Independent: Empowering Music Artists with AI and Brand Strategy
- Mental: Elderly Abuse a Documentary
- Consumer Accountability Alliance Issues Formal Notice Alleging Proximate Liability for Medical Harm
About the Heart Failure Society of America
The Heart Failure Society of America, Inc. (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care. The mission of HFSA is to provide a platform to improve and expand heart failure care through collaboration, education, innovation, research, and advocacy. HFSA members include physicians, scientists, nurses, nurse practitioners, pharmacists, trainees, other healthcare workers and patients. For more information, visit hfsa.org.
Media Contact: Laura Poko, 301-798-4493, ext. 226, [email protected]
SOURCE Heart Failure Society of America
Filed Under: Business
0 Comments
Latest on EntSun News
- John Duffy Competes in Mr Muscle Beach
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- Couture By Elesia Reclaims The Runway Of Everyday Life With Bold Return And New Hiya Sunshine Line
- BillBoards Inc. Hits the Road with God Bless America Tour and Reality Series Now Streaming on Tubi TV
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- Slipaway Food Truck Park & Marina announces opening weekend July 4-6
- 16-Year-Old Entrepreneur Discovers All-Natural Skincare Breakthrough That Works in Just 48 Hours
- Collision Course Concert Series Returns to Atlanta
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- BayView Entertainment, Inc. Releases Multi Award-Winning Horror Film 'The Forest Through the Trees'
- Germantown Fashion & Arts Festival 2025 Draws Thousands, Celebrates Creativity in Historic Philly
- The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
- Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
- New Media Film Festival Announces Winners
- New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
- The Herbal Care, Led by Markel Bababekov, Becomes a Top Dispensary in NYC's Upper East Side
- Digital Watchdog Launches New myDW Cloud Services
- Rock Artist Scott Pryor Reimagines Lady Gaga's "Bad Romance" in Explosive New Single Releasing July 11th